One year in review 2017: spondyloarthritis.

Authors:
Riccardo Terenzi
Riccardo Terenzi
Department of Experimental and Clinical Medicine
Italy
Sara Monti
Sara Monti
University of Pavia
Italy
Giulia Tesei
Giulia Tesei
University of Florence
Firenze | Italy
Linda Carli
Linda Carli
University of Pisa
Italy

Clin Exp Rheumatol 2018 Jan-Feb;36(1):1-14. Epub 2018 Feb 5.

GenOMeC PhD, University of Siena; and Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

The term spondyloarthritis (SpA) represents a condition characterised by a broad spectrum of clinical manifestations, laboratory abnormalities and imaging features; in particular, SpA is an inflammatory condition in which both peripheral and axial joints might be affected. The majority of people with this disease have either psoriatic arthritis or axial spondyloarthritis, which includes ankylosing spondylitis. Less common subgroups are enteropathic SpA, which is associated with inflammatory bowel diseases (Crohn's disease and ulcerative colitis), reactive arthritis, which can occur in people following gastrointestinal or genitourinary infections and undifferentiated SpA, that does not meet the diagnostic criteria of the other subgroups at onset, but that may evolve to do so later. Very interestingly, much of the emerging data show how SpA, during its course, tends to associate with the development of some comorbidities; in particular, with cardiovascular diseases, diabetes mellitus, osteoporosis and depressive disorders. Healthcare professionals in non-specialist settings do not always recognise the signs and symptoms of SpA, particularly spinal symptoms, which may be mistakenly attributed to other causes of low back pain, thus leading to significant delays in diagnosis and treatment of the disease itself and of its related comorbidities, with consequent disease progression and disability, compromising the health-related quality of life of patients. In this paper we reviewed the literature of the past year (Medline search of articles published from 1st March 2016 to 28th February 2017) with the aim of approaching the spectrum of SpA from some different points of view, to try to give the reader an insight into this clinically challenging group of rheumatic pathologies.
April 2018
8 Reads

Publication Analysis

Top Keywords

spa
7
disorders healthcare
4
healthcare professionals
4
depressive disorders
4
professionals non-specialist
4
osteoporosis depressive
4
cardiovascular diseases
4
diseases diabetes
4
diabetes mellitus
4
mellitus osteoporosis
4
non-specialist settings
4
recognise signs
4
symptoms mistakenly
4
mistakenly attributed
4
attributed low
4
low pain
4
spinal symptoms
4
spa spinal
4
comorbidities cardiovascular
4
signs symptoms
4

Similar Publications

Seronegative spondyloarthritis.

Best Pract Res Clin Rheumatol 2010 Dec;24(6):747-56

Menzies Research Institute, Hobart, Australia.

Seronegative spondyloarthritis (SpA) is a group of inflammatory rheumatic diseases with common clinical and aetiological features, including axial and peripheral inflammatory arthritis, enthesitis, extra-articular manifestations and a close link to the presence of the human leucocyte antigen (HLA)-B27 epitope. Ankylosing spondylitis is the most common of the SpA diseases, with prevalence in the Caucasian population ranging between 0.15% and 1. Read More

View Article
December 2010

Back pain and health status in patients with clinically diagnosed ankylosing spondylitis, psoriatic arthritis and other spondyloarthritis: a cross-sectional population-based study.

BMC Musculoskelet Disord 2016 Feb 27;17:106. Epub 2016 Feb 27.

Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Guldhedsgatan 10A, 405 30, Gothenburg, Sweden.

Background: In the broader spectrum of back pain, inflammatory back pain (IBP) is a symptom that may indicate axial spondyloarthritis (SpA). The objectives of this study were to determine the frequency of current IBP, as a hallmark sign of possible axial SpA, in patients with ankylosing spondylitis (AS), psoriatic arthritis (PsA) and other SpA and to compare self-reported health between the groups with current IBP.

Methods: Five-thousand seven hundred seventy one patients identified in the regional healthcare register of the most southern county of Sweden, diagnosed at least once by a physician (based on ICD-codes) with any type of SpA in 2003-2007, were sent a postal survey in 2009. Read More

View Article
February 2016

Optimisation of rheumatology assessments - the actual situation in axial spondyloarthritis including ankylosing spondylitis.

Clin Exp Rheumatol 2014 Sep-Oct;32(5 Suppl 85):S-96-104. Epub 2014 Oct 30.

Rheumazentrum Ruhrgebiet, Herne, Germany.

The spondyloarthritides (SpA) are currently differentiated into axial and peripheral SpA. Patients with axial SpA (axSpA) may be further classified into the classical form ankylosing spondylitis (AS) and non-radiographic axSpA (nr-axSpA). The SpA are genetically linked, and the subtypes including psoriatic arthritis (PsA) share characteristic clinical symptoms such as inflammatory back pain (IBP) and enthesitis. Read More

View Article
December 2014